rAAV Production via DMSO and Temperature Optimization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for large-scale production of adeno-associated virus (AAV) vectors face challenges in achieving consistent high yields necessary for commercial therapeutic use, requiring optimized production processes to maximize productivity.
Innovation Solution
The method involves introducing a polynucleotide comprising an rAAV genome into mammalian cells and culturing them in a medium with dimethyl sulfoxide (DMSO) and at elevated temperatures to enhance rAAV particle production, including specific temperature and pH conditions, and the use of additives like valproic acid, propionic acid, or butyric acid to optimize productivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional AAV production methods are used, then production process is simple, but productivity is insufficient for commercial therapeutic use
Solution Approach 1:
The patent applies parameter changes by optimizing culture conditions including temperature (30-42°C ranges), pH (6.5-7.5 ranges), dissolved oxygen levels (10-70% ranges), and nutrient concentrations to maximize AAV productivity. Different culture stages use different parameter sets to enhance vector genome production while maintaining process feasibility
Solution Approach 2:
The patent implements dynamic control of culture parameters throughout the production process. Temperature, pH, and oxygen levels are adjusted at different time points during cell culture and AAV production to optimize yields at each stage, transforming a static process into a dynamically optimized system
2Quantity of substance
If AAV production is scaled up for commercial use, then large amounts of AAV can be produced, but consistency of high yields becomes difficult to achieve
Solution Approach 1:
The patent incorporates monitoring and control of critical process parameters including pH, dissolved oxygen, temperature, and nutrient levels throughout the production process. This feedback control ensures consistent AAV yields by maintaining optimal conditions even as production scale increases
Solution Approach 2:
The patent establishes specific parameter ranges and optimization strategies that can be consistently applied across different production scales. By defining optimal temperature, pH, and nutrient conditions, the method ensures reproducible high yields whether producing small or large quantities of AAV
Data Source
AI summary
Provided herein are methods for the production of recombinant adeno-associated virus (rAAV) particles. These methods are particularly useful for the large-scale production of AAV particles.